Imunon, Inc.·4

May 27, 4:22 PM ET

Tardugno Michael H 4

4 · Imunon, Inc. · Filed May 27, 2026

Research Summary

AI-generated summary of this filing

Updated

Imunon (IMNN) Exec Chair Michael Tardugno Receives Stock Award

What Happened
Michael H. Tardugno, Executive Chairman and director of Imunon, Inc. (IMNN), was granted 3,484 shares of common stock on May 22, 2026. The award is reported at $2.20 per share for a total value of $7,665 and is coded as an acquisition/award (A). The grant was made in lieu of cash payment for base salary.

Key Details

  • Transaction date: 2026-05-22; price per share reported: $2.20; total value: $7,665.
  • Form filed: 2026-05-27 (filed within the required two-business-day reporting window).
  • Footnote: F1 — stock granted in lieu of cash for base salary.
  • Remarks: The filing notes a 15% stock dividend paid Aug 21, 2025 (record date Aug 7, 2025); previously reported share amounts were adjusted accordingly.
  • Shares owned after transaction: not specified in the filing.

Context
This was a compensation-related stock grant (award), not a market purchase or sale. Such awards are typically routine compensation and do not by themselves signal an insider buying or selling decision. The filing appears timely under Form 4 reporting rules.

Insider Transaction Report

Form 4
Period: 2026-05-22
Tardugno Michael H
DirectorExecutive Chairman of Board
Transactions
  • Award

    Common Stock

    [F1]
    2026-05-22$2.20/sh+3,484$7,6658,749 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    4,622
Footnotes (1)
  • [F1]Stock granted in lieu of cash for base salary
Signature
/s/ Susan Eylward, Attorney-in-Fact for Michael Tardugno|2026-05-27

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4